This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Direct Medical Cost for Surgical and Medical Treatment of Condylomata Acuminata

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We read with interest the article by Alam and Stiller,¹ in particular the conclusions that they reach as to the cost advantages of the treatment modalities considered for external genital warts (EGWs). We have concerns about the article and the conclusions that were reached. The methodology adopted by the authors is inappropriate with regard to the assessment of cost-effectiveness in treating a disease such as EGWs, in which recurrence is a critical issue. Regarding the article by Langley et al,² we were concerned that the impact of high recurrence rates in EGW treatment was only poorly understood and that physicians were accepting claims for cost-effectiveness based on models of treatment that do not represent the decisions faced in a real world environment. Unfortunately, Alam and Stiller explicitly exclude any consideration of recurrence and the long-run efficacy of treatment, therapy switching, and/or the use of combination therapy.³ As a result, their . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?